CACNA1A, calcium voltage-gated channel subunit alpha1 A, 773
N. diseases: 320; N. variants: 106
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
19 | 13286952 | frameshift variant | -/A | delins | 4.2E-06 |
|
Nervous System Diseases | 0.700 | 1.000 | 46 | 1988 | 2017 | |||||||||
|
19 | 13298882 | missense variant | C/G;T | snv | 0.13; 4.6E-06 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
19 | 13298658 | missense variant | T/A;C | snv | 0.14 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
19 | 13334405 | missense variant | C/T | snv | 8.0E-06 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | 0.800 | 1.000 | 22 | 1996 | 2017 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.830 | 1.000 | 13 | 1996 | 2018 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
0.700 | 1.000 | 8 | 1996 | 2017 | |||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
0.030 | 1.000 | 3 | 2002 | 2012 | |||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Nervous System Diseases | 0.030 | 1.000 | 3 | 1999 | 2019 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2004 | 2018 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.020 | 1.000 | 2 | 2004 | 2018 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2003 | 2003 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.010 | 1.000 | 1 | 1999 | 1999 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Eye Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.732 | 0.160 | 19 | 13303877 | missense variant | G/A | snv |
|
0.700 | 0 | ||||||||||||
|
0.752 | 0.240 | 19 | 13262771 | missense variant | C/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.752 | 0.240 | 19 | 13262771 | missense variant | C/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.700 | 0 | |||||||||||
|
0.752 | 0.240 | 19 | 13262771 | missense variant | C/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.752 | 0.240 | 19 | 13262771 | missense variant | C/A | snv |
|
Respiratory Tract Diseases; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.752 | 0.240 | 19 | 13262771 | missense variant | C/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.752 | 0.240 | 19 | 13262771 | missense variant | C/A | snv |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 0 | |||||||||||
|
0.752 | 0.240 | 19 | 13262771 | missense variant | C/A | snv |
|
0.700 | 0 |